Skip to main content
PLOS One logoLink to PLOS One
. 2022 Dec 20;17(12):e0279228. doi: 10.1371/journal.pone.0279228

Socioeconomic disparities in diabetes prevalence and management among the adult population in Bangladesh

Karar Zunaid Ahsan 1,*,#, Afrin Iqbal 2,#, Kanta Jamil 3,#, M Moinuddin Haider 4,, Shusmita Hossain Khan 5,, Nitai Chakraborty 5,6,, Peter Kim Streatfield 4,#
Editor: Mohammad Bellal Hossain7
PMCID: PMC9767371  PMID: 36538534

Abstract

Background

Diabetes, one of the major metabolic disorders, is rising in Bangladesh. Studies indicate there is inequality in prevalence and care-seeking behavior, which requires further exploration to understand the socioeconomic disparities in the pathophysiology of diabetes. This study examined the latest nationally representative estimates of diabetes prevalence, awareness, and management among adults aged 18 years and above in Bangladesh and its association with socioeconomic status in 2017–18.

Methods

We used the 2017–18 Bangladesh Demographic and Health Survey data. Diabetic status of 12,092 adults aged 18 years and above was measured in the survey using fasting plasma glucose levels. We applied multivariate logistic regressions to examine the role of socioeconomic status on diabetes prevalence, awareness, and management, after controlling for relevant covariates.

Results

Overall, 10% of adults had diabetes in Bangladesh in 2017–18, with the highest prevalence of 16% in the age group 55−64 years. Our analyses found statistically significant disparities by socioeconomic status in the prevalence of diabetes as well as the person’s awareness of his/her diabetic condition. However, the effect of socioeconomic status on receiving anti-diabetic medication only approached significance (p = 0.07), and we found no significant association between socioeconomic status and control of diabetes.

Conclusions

We expect to see an ‘accumulation’ of the number of people with diabetes to continue in the coming years. The rising prevalence of diabetes is only the tip of an iceberg; a large number of people with uncontrolled diabetes and a lack of awareness of their condition will lead to increased morbidity and mortality, and that could be the real threat. Immediate measures to increase screening coverage and exploration of poor control of diabetes are required to mitigate the situation.

Introduction

Diabetes Mellitus is one of the major metabolic disorders where glucose metabolism is disrupted, resulting in elevated levels of blood glucose (or blood sugar). It is defined as a fasting plasma glucose of 7.0 mmol/L (or 126 mg/dL) or above [1]. Among several types of diabetes, type 1, type 2, and gestational diabetes mellitus (GDM) are of major concern worldwide—type 1 diabetes is caused by an autoimmune reaction in the body where the immune system attacks the cells of the pancreas that produce insulin and, as a result, little or no insulin is produced in the body; type 2 diabetes occurs when the cells in our body become resistant to insulin resulting in prevention of the absorption of sugars; GDM is typically associated with high blood glucose levels occurring later in pregnancy and usually disappears after the pregnancy ends. Type 2 diabetes accounts for approximately 90% of the total diabetes burden, and the continued rise in diabetes prevalence globally is largely due to an upsurge in type 2 diabetes and related risk factors such as overweight/obesity, physical inactivity, and calorie-dense/unhealthy diet, as a result of urbanization and sedentary lifestyles [1, 2].

According to the International Diabetes Federation (IDF), there were an estimated 151 million people aged 20–79 years with type 2 diabetes in the year 2000 globally. This number has tripled to 463 million by 2019 and will continue to rise by approximately 9 million people every year until the mid-century [1]. Any type of uncontrolled and prolonged diabetes is associated with several complications, and it can damage the small and large blood vessels, heart, eyes, kidneys, and nerves over time. While some complications very specific to diabetes (e.g., retinopathy, nephropathy, neuropathy) can compromise the quality of life, other complications such as cardiovascular and cerebrovascular diseases are associated with premature deaths [3, 4]. For the reasons of increasingly early-onset and chronically long duration, type 2 diabetes accounts for 1.8% (1.02 million) of annual deaths globally, but for 2.3% of disability-adjusted life years lost (57.4 million disability-adjusted life years) in 2017 [5]. Globally total health expenditure for diabetes was estimated to be US $760 billion per year, primarily because of the chronic long-term morbidity associated with it [1].

Bangladesh is among the top ten countries in the world for the burden of diabetes, with around 8.4 million people with this chronic condition [1]. Two nationally representative surveys conducted in 2010 among adults 25 years or above and in 2018 among adults age 18−69 years reported national diabetes prevalence of 3.9% and 8.3%, respectively [6]. According to the Bangladesh Demographic and Health Survey (BDHS), diabetes prevalence among adults aged 35 years and above increased from 11.2% to 13.8% for females and 10.7% to 13.7% for males between 2011 and 2017–18 [7, 8]. Both the BDHS rounds show a slightly higher prevalence in females except for the 65+ age group. Approximately 57% of all women in Bangladesh belong to the reproductive age group of 15–49 years [9]. These women are subject to an additional risk of gestational diabetes, which may convert to type 2 diabetes, adding to the already high proportion of females with diabetes and related complicated cases in the country [10, 11].

The probability of dying prematurely from four major non-communicable diseases (NCDs), including diabetes, between ages 30 and 70 years has declined in many countries. Still, Bangladesh remains one of the only 20 countries where mortality has stagnated or increased from 2010 to 2016 [12]. It is often observed that undiagnosed cases present with more serious complications leading to premature death than diagnosed cases who are receiving treatment [13]. While the recent IDF estimates showed an alarming 56% of people with diabetes in Bangladesh to be undiagnosed [1], some nationally representative surveys reveal a similar picture. The 2017–18 BDHS showed 59% of females and 61% of males aged 18 years or above were unaware of their diabetic status [8]. The National STEPS Survey for NCD Risk Factors in Bangladesh 2018 also showed that 51% of people with diabetes were unaware of their condition [6]. Even among the adults aged 18 years or above who were diagnosed for having diabetes and were getting treatment, 25% of females and 22% of males did not have their blood glucose level under control [8]. The level of unawareness and uncontrolled blood glucose level among people with diabetes are major national public health concern and yet, have been relatively less prioritized.

There are visible inequalities in care-seeking and continuing treatment for chronic conditions such as diabetes. Several lifestyle behaviors, as well as knowledge and accessibility of healthcare, often drive the decision to get diagnosed and these factors are related to an individual’s socioeconomic status [14]. Several studies showed that those who are economically disadvantaged, or from a marginalized portion of the community tend to suffer from more grave complications related to NCDs, including diabetes, often leading to death [15]. While the role of individual-level socioeconomic characteristics in the pathophysiology of diabetes has been studied extensively in high-income countries, few studies have explored this association in low- and middle-income countries [16]. Particularly for Bangladesh, studies published in the last ten years examining the association between socioeconomic status and diabetes were either using the 2011 BDHS data [1723] or were based on small geographic locations [24, 25].

This study aimed to examine the latest nationally representative estimates of diabetes prevalence, awareness, and management among adults aged 18 years and above in Bangladesh and its association with socioeconomic status in 2017–18.

Methods

Study population and sampling

For this study, data from a nationally representative survey conducted between October 2017 and March 2018 was used. The 2017–18 BDHS is the eighth national survey, which reported the demographic and health status of women, men, and children from a nationally representative sample. The survey collected data from 20,250 households using a two-stage stratified cluster sampling process from 675 clusters in the first stage. A systematic sample of 30 households per cluster was selected in the second stage. BDHS provide statistically representative estimates of key demographic and health variables for the whole country, for urban and rural separately, and for each of the eight divisions. Details of the survey methodology can be found elsewhere [8].

The 2017–18 BDHS included measurements of biomarkers for the adult population. Blood pressure and blood glucose tests were done on all adults who were18 years and above in a quarter of the sampled households. BDHS also included height and weight measurements of all adults who were eligible for measuring blood pressure and testing blood glucose. To measure blood specimens for glucose testing, the respondents were asked to fast overnight for eight hours. They were visited early on the next day, and made sure that they had not broken their fast before the test. In most cases, the collection of blood specimens for glucose testing required two visits to a household. The HemoCue 201 RT analyzer was used to measure blood glucose level (in millimoles per liter—mmol/L). Capillary blood was obtained from the middle or ring finger of the respondent and those who gave their full consent to participate in blood glucose measurements were included. The survey excluded pregnant cases, which brought the final study sample size to 12,092 (6,913 women and 5,179 men) respondents aged 18 years and above (see S1 Fig in S1 File for the flowchart of analytic sample).

Outcome variables

The outcome variables for the study were: prevalence of diabetes, awareness of the respondent regarding their diabetic state, treatment status, and glycemic control among the people with diabetes. Respondents were identified as having diabetes if their fasting plasma glucose value was greater than or equal to 7.0 mmol/L on the day of the survey, or they were currently taking any medication for lowering blood glucose levels. Awareness was defined as the respondents with diabetes being aware that they have diabetes, conveyed to them by a physician or any health care provider. Treatment was defined as the respondents with diabetes who reported that they were currently taking any medication for diabetes on the day of the survey. Glycemic control was defined as the respondents with diabetes who had blood glucose below the threshold of 7.0 mmol/L while taking diabetes medication on the day of the survey.

Explanatory variables

While selecting the explanatory variables, we primarily used a conceptual framework developed by the American Diabetes Association and the availability of data in BDHS [26]. The variables included demographic factors (age and sex of the respondent), socioeconomic factors (household wealth quintile, educational status, place of residence), and biological factors (overweight/obesity, elevated blood pressure level).

Age of the respondents was self-reported, which was divided into five categories. Socioeconomic status of the respondents was calculated based on household wealth quintiles using principal component analysis of household assets and amenities—respondents belonging to the lowest two wealth quintiles were categorized as low, 3rd quintile as middle, and the highest two quintiles as high socioecoinomic status for the analysis. Level of educational attainment was divided into four different categories. Place of residence was categorized into urban or rural areas. Body mass index (BMI) was categorized into four groups—underweight if BMI is less than 18.5 kg/m2, normal if BMI is between 18.5 and 24.9 kg/m2, overweight or obese if BMI is 25 kg/m2 or above, and unknown for the respondents whose height and/or weight data were not available. Hypertensive was a binary variable where the respondent either had hypertension (i.e., systolic blood pressure was on or above 140 mmHg and/or diastolic blood pressure was on or above 90 mmHg on the day of the survey) or not. Following the definition used in the DHS, we also considered respondents as hypertensive who had a diagnosis of hypertension and currently taking antihypertensive medication, irrespective of their blood preassure status.

Conceptually meaningful two-way interaction terms of variables in the final main effects model were assessed with the aim of keeping significant ones, and no discernible pattern was found for significant (p<0.05) interaction between potential covariates. In addition, we checked for multicollinearity using both variance inflation factor (VIF) and multicollinearity condition number and carried out stratum-specific measures of association to identify effect modification in the model.

Statistical analyses

Univariate analyses of the explanatory variables were performed and presented in terms of frequencies. Later, bivariate analyses (cross-tabulations) between the outcome variables and individual covariates were carried out, followed by Rao-Scott second-order correction to Pearson’s Chi-square test to account for the complex survey design [27, 28]. The chi-squared test of independence is intended to test how likely it is that an observed distribution of two categorical variables is due to chance. Its robustness with respect to distribution of the data, applicability in studies where parametric assumptions remain unmet, and flexibility to deal with two or multiple groups have widened its application in scientific literature. In our bivariate analyses, we aimed to examine the association between diabetes prevalence, awareness, treatment, and control and the selected background characteristics that included more than one nominal variable. So, we preferred the chi-squared test. However, small sample size, fewer than required cell frequency and large number of categories may weaken the chi-squared test and provide biased significance. Our analysis is free of all these limitations. We haven’t used the Cramer’s V to assess the strength of the significant chi-square results as we included all the explanatory variables in the multivariate regression analysis (i.e., following our conceptual framework) irrespective of the corresponding significance of the chi-squared tests [29].

To examine the role of socioeconomic status affecting diabetes, a multivariate logistic regression model was used with the following regression specification:

logit(Yi)=lnπ1π=α+γiSi+βiXi+εi (1)

Where Yi is the outcome of interest, which is a dichotomous variable with the value equal to 1 if the individual i has diabetes (0 otherwise); π is the probability of having diabetes for individual i (i.e., Yi = 1); Si is the socioeconomic status of individual i; Xi is a vector of relevant socio-demographic covariates that influence the outcome. Following the model specification in Eq (1), factors affecting diabetes prevalence, awareness, treatment, and control were examined by estimating the adjusted odds ratio (aOR) from separate multivariate logistic regression models. Stata v.16 was used for analysis, and appropriate sampling weights for BDHS 2017–18 were applied using Stata’s survey estimation procedures (“svy” command) to get nationally representative estimates of the adult population of Bangladesh after adjusting for sample strata and clusters.

Ethics approval

Demographic and Health Survey Data collection procedures for the 2017–18 BDHS were approved by the Institutional Review Boards of the ICF International, Rockville, MD, USA and Bangladesh Medical Research Council, Dhaka, Bangladesh. Informed consent was obtained from all respondents in the survey before asking questions, and separately before obtaining biomarker and anthropometric measurements. Respondents who did not provide consent were excluded from the analysis for the current study.

Results

General characteristics of study participants

Table 1 shows the characteristics of the sampled respondents aged 18 years and above in the 2017–18 BDHS. Our study sample comprised 45% young adults aged 18–34 years, 57% females, and 74% rural residents. Nearly a quarter of the sample was overweight or obese, and 28% were hypertensive.

Table 1. Characteristics of the study population, Bangladesh 2017–18.

Background characteristics Number Percentage
Age (in years)
 18–34 5418 44.8
 35–44 2427 20.1
 45–54 1680 13.9
 55–64 1362 11.3
 65+ 1204 10.0
Sex
 Male 5179 42.8
 Female 6913 57.2
Educational attainment
 No education 3116 25.8
 Primary 3618 29.9
 Secondary incomplete 3136 25.9
 Secondary complete or higher 2223 18.4
Wealth index
 Low 4729 39.1
 Middle 2492 20.6
 High 4870 40.3
Locality
 Urban 3208 26.5
 Rural 8883 73.5
Body mass index (BMI)
 Underweight 2068 17.1
 Normal 7013 58.0
 Overweight/obese 2878 23.8
 Unknowna 132 1.1
Hypertensive
 No 8753 72.4
 Yes 3338 27.6
Total 12092 100.0

Note: a Either height or weight or both were missing.

Diabetes among Bangladeshi adults in 2017–18

Approximately one in ten (9.9%) adults aged 18 years or above were diagnosed to have diabetes in Bangladesh. Between age groups 18−34 and 35−44 years, the prevalence of diabetes more than doubled from 5.3% to 11.1% and was higher among the older age groups. Surprisingly, we observed a slight reduction (from 15.8% to 15.1%) in diabetes prevalence among those aged 65 years or above compared to their younger age group of 55−64 years. Females showed a slightly higher prevalence of diabetes than males except for the age group 65 years or more (see Fig 1).

Fig 1. Prevalence of diabetes by age group and sex in Bangladesh, 2017–18.

Fig 1

For our bivariate analyses, we carried out chi-squared tests to determine whether there was an association between the selected explanatory variables based on the conceptual framework and diabetes prevalence, awareness, treatment, and control. Given the multiple numbers of tests performed under bivariate analyses, we estimated the Bonferroni corrected p-value to be 0.0011, meaning p-values over this threshold are not significant [30]. Considering the Bonferroni-corrected p-value threshold, having diabetes was significantly positively associated with age, socioeconomic status, BMI, hypertensive status, and urban residence. While there was no evidence of association with gender or educational attainment in bivariate analyses (see Table 2), only 6% of the people from low socioeconomic status had diabetes, which increased to 15% for the high socioeconomic status (p<0.001). The prevalence of diabetes was around 8% among people living in rural areas, who were normal/underweight, and was non-hypertensive. Prevalence was nearly double among overweight/obese people and hypertensives (p<0.001). From the bivariate analyses, we also found that among the adults with diabetes, awareness and taking medication were significantly associated with age, socioeconomic status, BMI, and hypertensive status (p<0.001). Among the adults with diabetes, having their diabetic condition under control was significantly associated only with age (p<0.001) and hypertensive status (p = 0.0011).

Table 2. Prevalence, awareness, and management of diabetes among the adult population by background characteristics, Bangladesh 2017–18.

Background characteristics Prevalence of diabetes Among the respondents with diabetes who are:
Aware of condition Taking medications Controlled blood glucose level
Percent χ2 test p-value Percent χ2 test p-value Percent χ2 test p-value Percent χ2 test p-value
Age (years)
 18–34 5.3 <0.001 14.5 <0.001 12.5 <0.001 2.8 <0.001
 35–44 11.1 32.2 29.6 7.2
 45–54 14.9 48.5 44.0 14.5
 55–64 15.8 55.7 51.8 15.3
 65+ 15.1 51.6 46.2 18.4
Sex
 Male 10.5 0.072 37.1 0.443 33.3 0.337 10.8 0.995
 Female 9.5 39.7 36.4 10.8
Education
 No education 9.9 0.274 40.6 0.007 37.3 0.006 12.7 0.108
 Primary 10.2 30.5 27.2 10.5
 Secondary incomplete 9.1 41.8 36.6 6.9
 Secondary complete or higher 10.9 44.4 42.1 13.3
Socioeconomic status
 Low 5.9 <0.001 26.8 <0.001 25.4 0.001 10.7 0.827
 Middle 8.0 36.6 31.4 12.2
 High 14.9 43.5 39.7 10.5
Locality
 Urban 13.3 <0.001 37.0 0.468 33.9 0.600 9.3 0.237
 Rural 8.7 39.4 35.6 11.6
BMI
 Underweight 6.2 <0.001 19.1 <0.001 19.1 <0.001 11.0 0.906
 Normal 8.6 38.5 34.8 10.9
 Overweight/obese 15.6 44.0 39.9 10.4
 Not measured 14.8 42.0 32.9 15.3
Hypertension status
 Not hypertensive 7.4 <0.001 26.3 <0.001 23.4 <0.001 8.0 0.0011
 Hypertensive 16.6 53.0 48.8 14.2
Total 9.9 - 38.5 - 35.0 - 10.8 -
Number of respondents 12092 1201 1201 1201

Note: Bonferroni-corrected p-value threshold for multiple testing is 0.0011

Close to 40% of adults with diabetes are aware of the condition, 35% take medication, and 11% have their diabetic condition under control. In other words, while more than 90% of the respondents with diabetes who are aware of their condition take required medications, fewer than one in three are able to keep their condition under control (see Fig 2). A simple simulation, based on these estimates, indicates increasing awareness to 100% among the people with diabetes would increase the use of medication to 91% from currently 35%. This may improve blood glucose control to 28% from currently 11%. The analyses assumed the medication status, including the provider and the client compliances, remained unchanged.

Fig 2. Diabetes care cascade, Bangladesh 2017–18.

Fig 2

Similar to prevalence, awareness of diabetes and medication among the respondents with diabetes increased with age and higher socioeconomic status (see Table 2). Male-female and urban-rural differences were small and not statistically significant. Levels of education, BMI, and hypertensive status were significantly associated with awareness of the condition and taking medications. Except for age and hypertensive status, no other background characteristics were significantly associated with blood glucose control among the respondents with diabetes. Older and hypertensive individuals appeared to have better control of their blood glucose levels.

Correlates of diabetes among Bangladeshi adults

In a multivariate logistic regression model, an adjusted odds ratio (aOR) denotes an odds ratio that has been adjusted to account for other explanatory variables. In this study, we included seven explanatory variables in the logistic regression following the conceptual framework. Therefore, the corresponding odds ratio of one variable is adjusted for the other six variables, and we address that as an aOR. We used the aORs as a tool to examine the association of diabetes with selected socioeconomic, demographic, and health status-related factors (i.e., correlates), and followed standard practices for its mathematical specification and explanation [31, 32]. Correlates of diabetes that were statistically significant in bivariate analyses remained significant even after adjusting for background characteristics (see Table 3). There was a clear socioeconomic gradient for diabetes prevalence—compared to the low socioecnomic status, the odds of having diabetes was 1.3 and 2.4 times higher for people from the middle and the high socioeconomic status (p<0.05 and p<0.001, respectively). The odds of having diabetes for the youngest age group (18−34 years) was half than their older age group coungerparts (35−44 years) (p<0.001). Using the same reference age group, the odds were 1.4 times higher among people age 45−54 years and 1.6 times higher among people age 55 years or above (p<0.05 and p = 0.001, respectively). The odds of overweight/obese people having diabetes was nearly 1.5 times than those which have normal BMI. People with hypertension had nearly 2.6 times higher odds of having diabetes than those who were not (p<0.001). Although the odds of having diabetes was found to be higher with educational attainment compared with no education, the aOR was only significant for primary education in our analysis. Our logistic regression model also indicated the odds of having diabetes was lower among people living in rural areas, but the significance level fell outside the traditional threshold (p = 0.089).

Table 3. Adjusted odds ratios of diabetes prevalence, awareness, and management among the adult population, Bangladesh 2017–18.

Background characteristics Has diabetes Aware of condition Taking medications Controlled blood glucose level
aOR p-value 95% CI aOR p-value 95% CI aOR p-value 95% CI aOR p-value 95% CI
Age (reference category: 35–44 years)
 18–34 0.48 <0.001 0.39–0.59 0.32 <0.001 0.20–0.51 0.31 <0.001 0.19–0.50 0.36 0.018 0.16–0.84
 45–54 1.40 0.002 1.13–1.74 1.92 0.002 1.27–2.91 1.77 0.006 1.17–2.66 2.16 0.019 1.14–4.11
 55–64 1.60 <0.001 1.27–2.01 2.59 <0.001 1.65–4.06 2.51 <0.001 1.59–3.94 2.41 0.008 1.25–4.65
 65+ 1.57 0.001 1.20–2.05 2.62 <0.001 1.61–4.27 2.31 0.001 1.41–3.78 2.98 0.002 1.48–6.02
Sex (reference category: male)
 Female 0.97 0.622 0.84–1.11 1.53 0.008 1.12–2.10 1.59 0.004 1.16–2.19 1.36 0.180 0.87–2.13
Education (reference category: no education)
 Primary 1.31 0.006 1.08–1.59 0.93 0.728 0.60–1.42 0.91 0.682 0.58–1.42 1.25 0.432 0.71–2.20
 Secondary incomplete 1.20 0.119 0.96–1.50 1.92 0.007 1.20–3.06 1.73 0.026 1.07–2.78 1.03 0.939 0.53–1.97
 Secondary complete+ 1.23 0.122 0.95–1.59 2.12 0.002 1.32–3.43 2.29 0.001 1.41–3.71 2.18 0.023 1.12–4.27
Socioeconomic status (reference category: low)
 Middle 1.29 0.034 1.02–1.64 1.34 0.249 0.81–2.20 1.11 0.660 0.68–1.84 1.04 0.910 0.54–2.01
 High 2.35 <0.001 1.90–2.90 1.60 0.031 1.04–2.45 1.44 0.092 0.94–2.20 0.81 0.410 0.48–1.34
Locality (reference category: urban)
 Rural 0.86 0.093 0.73–1.03 1.28 0.123 0.94–1.76 1.24 0.180 0.91–1.69 1.11 0.619 0.72–1.73
BMI (reference category: normal)
 Underweight 0.79 0.053 0.62–1.00 0.42 0.009 0/22-0.81 0.52 0.044 0.27–0.98 1.11 0.798 0.51–2.40
 Overweight/obese 1.47 <0.001 1.25–1.71 0.96 0.797 0.69–1.33 0.94 0.702 0.68–1.29 0.90 0.658 0.57–1.42
 Not measured 1.15 0.583 0.70–1.91 0.57 0.231 0.23–1.43 0.46 0.084 0.19–1.11 0.94 0.909 0.31–2.82
Hypertensive status (reference category: not hypertensive)
 Hypertensive 1.57 <0.001 1.35–1.82 1.95 <0.001 1.44–2.63 2.00 <0.001 1.47–2.72 1.34 0.149 0.89–2.01
Constant 0.05 <0.001 0.04–0.08 0.14 <0.001 0.07–0.26 0.13 <0.001 0.07–0.25 0.05 <0.001 0.02–0.12
Number of respondents 12092 1201 1201 1201

Note: aOR: adjusted odds ratio; CI: confidence interval.

The odds of being aware of diabetes was more strongly associated with socioeconomic status than the odds of taking anti-diabetic medications. The odds of respondents with diabetes from the high socioeconomic status was 1.6 times higher to be aware of their condition than the respondents with diabetes from the low socioecnomic status (p<0.05) (see Table 3). The odds of being aware and taking medications also increased with age. Unlike diabetes prevalence, odds of awareness and medication were found to be gender-dependent, with females having 1.5 and 1.6 times higher odds to be aware of the condition or for taking medications, respectively (p<0.05). As expected, people educated higher than primary levels had higher odds to be aware of their diabetic condition than their counterpart with no education, while the odds of taking medication was two-times higher among those who completed at least secondary education (p<0.001). When biological correlates were considered, respondents with both hypertension and diabetes had nearly two-times higher odds to be aware and to take medications (p<0.001). Both awareness of and medication for diabetes were independent of urban/rural residence and BMI.

We also found using our multivariable logistic regression model that a person’s gender, wealth status, urban/rural residence, BMI, and hypertensive status were not associated with control of diabetes (see Table 3). When adjusted for possible explanatory variables, the odds of having diabetes under control was 1.3 times higher among people with hypertension than non-hypertensives, although the statistical significance was lost (Table 3). Our analysis found older age and higher education attainment (completion of secondary education or more) significantly increased the odds of having diabetes under control (p<0.05).

Discussion

From the most recent nationally representative survey data, we estimated that 9.9% of the population aged 18 years and above had diabetes in Bangladesh in 2017–18, which is substantially higher than the available country estimates from commonly used global sources such as IDF or WHO [1, 33]. IDF estimated 8.4 million adults in Bangladesh to have diabetes in 2019 [1], whereas our estimated diabetes prevalence translates into 10.8 million people using the 2019 population estimates from the United Nations [34]. Between 2011 and 2017–18, the overall diabetes prevalence among Bangladeshi adults aged 35 years or above increased from 11.0% to 13.7%, which is equivalent to a growth rate of 4.1% annually. It is unusual for a chronic condition to change so rapidly, so we first looked into explaining the rapid rise in diabetes levels in Bangladesh. An analysis of causes of death data from a rural sub-district of Bangladesh over 30 years period indicated Bangladesh was already at the third stage of epidemiological transition from acute, infectious, and parasitic diseases to degenerative, chronic NCDs [35]. At the current stage of epidemiological transition, the burden of major NCDs like diabetes, cardiovascular disease, and cancers is likely to increase in the coming years. Another possible reason for the rapid rise in diabetes levels would be changing patterns of diabetes risk factors (e.g., socioeconomic status and other social determinants of health, age, BMI, co-morbidities like hypertension), which are discussed below.

We found higher socioeconomic status to be a strong determinant of diabetes. This is in line with other studies [15, 16, 22, 23, 3639], but contradicts the findings from high-income countries where diabetes prevalence was more concentrated among the poor [26, 40]. In our analysis, socioeconomic status played a statistically significant role in predicting the likelihood of an individual having diabetes and influencing an individual’s awareness of having the disease. However, the influence of socioeconomic status on the likelihood of receiving anti-diabetic medication only approached significance (p = 0.07), and we found no significant association between socioeconomic status and control of diabetes. A study by Rahman and colleagues on the 2011 BDHS found diabetic individuals belonging to the lower socioeconomic group were less likely to be aware of their condition and less likely to be under anti-diabetic medication primarily due to the high cost of diabetes care [19]. A recent study found that the total annual per capita expenditure on medical care to be 6.1 times higher for people with diabetes than non-diabetics [41]. The increasing prevalence of diabetes and fewer diabetics being aware and taking medication could imply a huge burden of medical care cost nationally, most of which is paid out of pocket.

A systematic review by Grintsova et al. (2014) from high-income countries, where inequalities exist across different healthcare systems, found a trend towards worse healthcare for patients with low socioeconomic status and people with diabetes living in deprived areas less often achieve glycemic control targets [42]. Our study, however, indicated that people from high socioeconomic status were not significantly better than low socioeconomic status in achieving glycemic control. One possible reason for such a finding could be that lifestyle-related risk factors of chronic diseases are highly prevalent in South Asia, and Bangladesh has the worst risk factor profile among the nations in the region [24, 43, 44]. Among the lifestyle-related factors, diet composition as well as excess energy intake are the main contributing factors—the socioeconomically better-off class and urban residents are increasingly being exposed to processed food, sugar-sweetened beverages, and trans-fats, and there is no clear guideline in the country yet to restrict these contents in the food products [24, 45, 46]. A study on knowledge and self-care practices regarding diabetes found that despite high knowledge level regarding diabetes among the sampled diabetic population, about 90% of respondents did not test their blood glucose regularly or did not follow dietary advice given by diabetes educators, and only about one-third of respondents partially followed rules for portion control before eating [47].

Older age was also found to be a powerful determinant of diabetes among Bangladeshi adults, which is consistent with the findings from recent studies elsewhere [40, 4852]. Age contributes to the pathophysiology of diabetes, type 2 diabetes in particular, due to the combined effects of increasing insulin resistance and impaired pancreatic function with aging [53]. Since diabetes is a chronic condition and is carried throughout life, about three-quarters of diabetics who have the condition in 2010 would still have it in 2020, when they would be a decade older. In addition, a further two million new cases would have been added each year in Bangladesh during that decade. With declining fertility and a steady increase in life expectancy in Bangladesh (between 2010 and 2019, life expectancy at birth for males increased from 67 to 71 years and for females from 69 to 74 years) [54], we may expect to see ‘accumulation’ of the number of people with diabetes to continue in the coming years. Older age was also found to be a statistically significant determinant for increasing awareness, treatment initiation, and control of diabetes. Routine health screening recommendations explicitly incorporate older adults (viz. middle-aged and above) to be screened for diabetes in most countries [55]. Bangladesh’s National NCD Program currently uses an age threshold of 40 years or older (and any pregnant women) for initial screening for diabetes at a primary-level health facility (community clinics and Upazila health complexes—UHCs) for any service contact, which may have increased the likelihood of diagnosis and treatment at an older age. Survival bias may also be a reason for a higher level of diagnosis at older ages as individuals who have uncontrolled diabetes or complications related to diabetes are more likely to die at a younger age compared to individuals who had a late onset of the condition and/or controlled it well, [56] making the latter groups over-represented in large, population-based cross-sectional surveys. Though diabetes is a progressive condition and blood glucose levels are known to increase with age, individuals diagnosed with type 2 diabetes at younger ages and being diabetic for a longer duration may, in the long run, have a more severe form of the disease and find it more difficult to achieve glycemic control with current treatment modalities [57]. This phenomenon may explain why some older individuals have significantly better control of diabetes compared to some younger adults as they may have late onset of diabetes.

Excess weight is associated with an increased prevalence of diabetes, hypertension, and certain cancers. In addition, both obesity and diabetes are associated with an increased risk for cardiovascular disease-related mortality and other mortalities [58]. A recent study found that the chance of developing diabetes among overweight adult persons was double that of their normal-weight counterparts in Bangladesh [59]. An important finding for Bangladesh from this study is that overweight and/or obese persons are more likely to have diabetes but not more likely to be aware, taking medications, or controlling their blood glucose levels.

It was surprising that the place of residence (urban/rural) was not significantly associated with the diabetes outcomes used in our study, after controlling for relevant covariates. In many other studies, diabetes prevalence tends to be higher in urban areas, even in Bangladesh [23, 38, 39]. Though the lifestyle is expected to be less sedentary in rural areas than in urban cities, overall socioeconomic improvement and high consumption of rice may partly explain the narrowing gap in diabetes prevalence in rural and urban areas in recent years. Studies found that the most popular, high yielding rice varieties in Bangladesh have a very high glycemic index [60, 61]. As expected, higher educational attainment was found to be significantly associated with diabetes awareness, treatment, and control of blood sugar levels.

Our findings from the diabetes care cascade (see Fig 2) revealed that 62% of the people with diabetes are unaware that they have diabetes. This level of undiagnosed diabetes is higher than the regional average (57%) or for middle-income countries (53%) and more in line with low-income countries 67% [1]. The findings also showed that though the gap to treatment initiation once diagnosed is small (i.e., 91% of diagnosed people having anti-diabetic medication), only a third of them were able to reach the recommended lower blood glucose level. Overall, only one-in-nine diabetic persons were able to control their diabetes in 2017–18, which is slightly lower than the 2011 level (12.5%). Given the current status of diabetes control, even if we were able to increase awareness to 100% among people with diabetes, only 28% would be able to achieve the required blood glucose level. This calls for immediate attention to the existing health service delivery mechanism for diabetes in the country. The most recent health facility survey in Bangladesh indicated 53% of health facilities in Bangladesh offered services for diabetes (that is, providers in the facility diagnose, manage, and prescribe treatment for people with diabetes) in 2017, a substantial increase from 18% in 2014 [62]. A health facility was classified as “ready” to provide services for a specific NCD if all the following components were present: relevant guidelines; at least one trained provider; necessary equipment, diagnostic supplies, and medicines [63]. Using this globally acceptable standard of service readiness, the 2017 Bangladesh Health Facility Survey indicated that none of the existing health facilities have all components present to deliver diabetes services—only 17% of facilities had guidelines for diagnosis and management of diabetes available on the day of the survey; 33% had staff ever trained in diabetes; 54% had blood glucose testing capacity, while 46% had urine protein and urine glucose testing capacity; 40% of facilities had metformin, and 29% had injectable insulin, 9% had glibenclamide, and 19% had injectable glucose solution available [62]. Low readiness for diabetes services was found in other studies based on Bangladesh as well [6466].

In summary, our analyses clearly indicated that adults from higher socioeconomic status were significantly more likely than those from low socioeconomic status to become diabetic, be aware of their condition, and be under medication, but not significantly better in achieving glycemic control. With Bangladesh’s ongoing economic progress and demographic transition, we may expect to see an ‘accumulation’ of the number of people with diabetes to continue in the coming years. Given the increasing number of diabetes cases in the country and low level of awareness as well as glycemic control among the people with diabetes, the traditional physician-centric healthcare delivery system in Bangladesh appears to be inadequate to meet the demands for diabetes treatment and management [67]. In order to design effective diabetes screening and management services to maximize NCD coverage in the future, the following policy and programmatic interventions can be considered:

  1. Expand coverage of facility-based services for diabetes in all sectors: The government’s policy on screening and management of diabetes has not been consistent over the years. Under the national health sector program for 2011–2016, 300 UHCs and corresponding community clinics provided diabetes (and hypertension) screening [68]. In the subsequent health sector program for 2017–22, however, the government moved away from this screening initiative and started piloting an NCD management model in 62 out of 492 upazilas (sub-districts) to provide comprehensive screening, referral, and management services. The government needs to scale up the piloting without delay and initiate screening in the rest of the primary-level public facilities (i.e., 13,442 community clinics, 420 UHCs, 98 mother and child welfare centers, 4,011 union health and family welfare centers, 1,275 union sub-centers, and other sub-district/union-level hospitals) to expand the service coverage for diabetes [62]. Since the expected number of people with diabetes in the country cannot be handled by the public sector alone, the government needs to explore alternative options and take advantage of the presence of private sector and non-governmental organizations (NGOs) to train non-physicians to conduct screening and follow-up examinations to handle non-complicated/non-critical cases with appropriate referral chain guidelines. While the expansion of service coverage through the public sector will largely cover the rural areas, it would be more resource-efficient to engage the private and NGO sectors to cover the urban cities.

  2. Revise the existing screening and management modalities: The age threshold for the initial NCD screening at primary-level health facilities and referral as per the National NCD Program protocol need to be reduced to 35 years (from 40 years) to expand screening coverage for both diabetes and hypertension. Our analysis indicates that diabetes prevalence doubled after age 35 years, and the proposed change in age threshold for screening will be able to identify the people with diabetes earlier for better treatment. In collaboration with the government’s NCD Program, BADAS recently finalized a comprehensive Diabetes Care Guideline [69], which needs to be implemented nationwide to ensure a consistent, integrated approach for diabetes screening, treatment, and management in the country. The government may also explore opportunities for public-private partnerships to nationally scale up BADAS’ Health Care Development Program, which is currently piloting a model of integrated care service delivery in urban and rural areas with a focus on the integrated healthcare approach for diabetes and other major NCDs [70].

  3. Improve health system’s capacity for diabetes management: The low readiness of health facilities for diabetes management as shown by the 2017 Bangladesh Health Facility Survey can be addressed by training health providers in diabetes diagnosis and management, making available guidelines and protocols, increasing diagnostic and laboratory capacities, and ensuring the stock of medicines such as metformin, insulin, and glibenclamide. The planning and procurement capacities of the National NCD Program also need to be improved to ensure an uninterrupted supply of drugs, equipment, and laboratory reagents to the health facilities. Under the ongoing health sector program, there are provisions for program capacity development through technical assistance, which can be utilized by the National NCD Program.

  4. Explore innovative approaches to improve awareness and medication compliance: Our analyses indicated that higher socioeconomic status was positively associated with diabetes prevalence, awareness, and medication but not with achieving glycemic control. To improve knowledge and medication compliance among the better-off individuals, innovative measures utilizing mobile and information technology can be explored. A randomized controlled trial in Bangladesh showed that in people with type 2 diabetes attending a specialized hospital, improvement of glycemic control could be achieved by mobile phone text messaging [71]. Public health campaigns alone, while they can increase awareness, have not proven effective in preventing diabetes [72]. Use of social media and mobile phone text messaging may, therefore, provide efficient and cost-effective approaches to increase diabetes knowledge, improve self-care and management, and enhance healthcare seeking behavior among the people with diabetes.

  5. Strengthen the government’s stewardship role to implement multisectoral actions: Diabetes prevention and control require strong national stewardship of the government’s Ministry of Health and Family Welfare (MOHFW) to coordinate a meaningful multisectoral response. In 2018, the MOHFW adopted a multisectoral action plan for prevention and control of NCDs that involved 30 ministries and agencies [73]. The MOHFW needs to strengthen its stewardship capacity to coordinate interaction with other sectors and agencies to implement the following actions as priority: formulate guidelines to restrict sugar and trans-fat contents in the food products (with the ministries of Food, Commerce, and Industries); promote healthy diets by switching from very high glycemic index rice varieties (with the ministries of Agriculture, Food, and Commerce); and promote healthy lifestyle (with the ministries of Education, Food, Local Government, Housing and Public Works, and Youth and Sports).

Strengths and limitations

Our study provides evidence of the correlates of diabetes using the most recent nationally representative sample. To our knowledge, this is the first survey in Bangladesh, which collected information on diabetes for the adult (i.e., 18 years and older) population by using World Health Organization recommended guidelines. In this analysis, we accounted for the sample stratification and clustering in the BDHS so that the findings are truly representative of the national status in terms of diabetes estimates.

Unlike the main module of the BDHS questionnaire, where the response rate was 99%, the non-response rate for the biomarker questionnaire was high—16.3% of the respondents either were not available or refused to participate in blood glucose measurements, yielding a response rate of 83.7%. We performed an empirical diagnostic check to ensure that our final sample continues to be representative of the total sample, and consequently, the country population (see S1 Table in S1 File). Lastly, multivariable regression analyses in this study were conducted on a single round of cross-sectional data (i.e., BDHS 2017–18) separately for diabetes prevalence, awareness, treatment, and control, and no post-hoc analysis like Bonferroni correction for multiple-hypothesis testing was performed.

Conclusion

Comparable estimates of diabetes prevalence among older adults in Bangladesh indicate a steady rise in diabetes in recent years, which would hinder achieving the health-related Sustainable Development Goals by 2030. The rising prevalence of diabetes is only the tip of the iceberg, while the huge number of people with diabetes being unaware of their uncontrolled blood glucose level leading to increased morbidity and mortality could be the real threat. Immediate measures to increase screening coverage and exploration of poor control of diabetes is required to mitigate the situation. The involvement of private sector and NGOs, coupled with innovative measures utilizing mobile and information technology, should also be explored to provide support for people with diabetes in Bangladesh.

Supporting information

S1 File

(DOCX)

Acknowledgments

icddr,b acknowledges with gratitude the commitment of USAID to its research efforts. icddr,b is also grateful to the Governments of Bangladesh, Canada, Sweden, and the UK for providing core/unrestricted support. We also acknowledge the institutions and individuals who had made the 2017–18 Bangladesh Demographic and Health Survey possible. This work could not have been done without the full support of the BDHS Technical Working Group (TWG), which includes representatives from NIPORT, The DHS Program, MEASURE Evaluation, Data for Impact (D4I), icddr,b, and USAID/Bangladesh for designing and implementing the surveys. The 2017–18 BDHS data were collected and processed by Mitra & Associates. Lastly, the authors would like to thank the participants of the Bangladesh Demographic and Health Surveys who participated in this study.

Data Availability

The survey data reported in this manuscript are publicly available via the DHS Program. The BDHS 2017-18 datasets are freely available from the following website: http://dhsprogram.com/data/available-datasets.cfm.

Funding Statement

This work was supported by USAID’s Research for Decision Makers (RDM) activity, cooperative agreement no. AID-388-A-17-00006 [GR: 154601546], and Data for Impact (D4I) associate award no. 7200AA18LA00008.

References

  • 1.International Diabetes Federation. IDF Diabetes Atlas 2019. Ninth Ed. Brussels: IDF; 2019. [Google Scholar]
  • 2.Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843 [DOI] [PubMed] [Google Scholar]
  • 3.Nathan DM. Long-term complications of diabetes mellitus. New England Journal of Medicine. 1993;328:1676–85. doi: 10.1056/NEJM199306103282306 [DOI] [PubMed] [Google Scholar]
  • 4.Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88–98. doi: 10.1038/nrendo.2017.151 [DOI] [PubMed] [Google Scholar]
  • 5.Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2017 (GBD 2017) Results: Type 2 Diabetes. 2020. http://ghdx.healthdata.org/gbd-results-tool. Accessed 18 Sep 2020.
  • 6.National Institute of Preventive and Social Medicine (NIPSOM). National STEPS Survey for Non-communicable Diseases Risk Factors in Bangladesh 2018. Dhaka, Bangladesh; 2020.
  • 7.National Institute of Population Research and Training (NIPORT), Mitra and Associates, ICF International. Bangladesh Demographic and Health Survey 2011. Dhaka, Bangladesh, and Calverton, Maryland, USA; 2013.
  • 8.National Institute of Population Research and Training (NIPORT), ICF. Bangladesh Demographic and Health Survey 2017–18: Final Report. Dhaka, Bangladesh, and Rockville, Maryland, USA; 2020.
  • 9.United Nations, Department of Economic and Social Affairs PD. Percentage of female population by broad age group: Bangladesh 2020. World Population Prospects 2019, custom data acquired via website. 2019. https://population.un.org/wpp/DataQuery/. Accessed 20 Sep 2020.
  • 10.Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. The Lancet. 2009;373:1773–9. doi: 10.1016/S0140-6736(09)60731-5 [DOI] [PubMed] [Google Scholar]
  • 11.Song C, Lyu Y, Li C, Liu P, Li J, Ma RC, et al. Long-term risk of diabetes in women at varying durations after gestational diabetes: a systematic review and meta-analysis with more than 2 million women. Obesity Reviews. 2018;19:421–9. doi: 10.1111/obr.12645 [DOI] [PubMed] [Google Scholar]
  • 12.NCD Countdown 2030 Collaborators. NCD Countdown 2030: pathways to achieving Sustainable Development Goal target 3.4. The Lancet. 2020;6736:1–17. doi: 10.1016/S0140-6736(20)31761-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Beagley J, Guariguata L, Weil C, Motala AA. Global estimates of undiagnosed diabetes in adults. Diabetes Res Clin Pract. 2014;103:150–60. doi: 10.1016/j.diabres.2013.11.001 [DOI] [PubMed] [Google Scholar]
  • 14.Blas E, Kurup AS, editors. Equity, social determinants and public health programmes. Geneva: World Health Organization; 2010. [Google Scholar]
  • 15.Di Cesare M, Khang YH, Asaria P, Blakely T, Cowan MJ, Farzadfar F, et al. Inequalities in non-communicable diseases and effective responses. The Lancet. 2013;381:585–97. doi: 10.1016/S0140-6736(12)61851-0 [DOI] [PubMed] [Google Scholar]
  • 16.Seiglie JA, Marcus ME, Ebert C, Prodromidis N, Geldsetzer P, Theilmann M, et al. Diabetes prevalence and its relationship with education, wealth, and BMI in 29 low- And middle-income countries. Diabetes Care. 2020;43:767–75. doi: 10.2337/dc19-1782 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Chowdhury MAB, Uddin MJ, Khan HMR, Haque MR. Type 2 diabetes and its correlates among adults in Bangladesh: a population based study. BMC Public Health. 2015;15:1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Rahman M, Emdadul SH, Islam MdJ, Mostofa MdG, Saadat KA. Association of socioeconomic status with diagnosis, treatment and control of hypertension in diabetic hypertensive individuals in Bangladesh: a population-based cross-sectional study. JRSM Open. 2015;6:1–11. doi: 10.1177/2054270415608118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Rahman M, Nakamura K, Kizuki M. Socioeconomic differences in the prevalence, awareness, and control of diabetes in Bangladesh. J Diabetes Complications. 2015;29:788–93. doi: 10.1016/j.jdiacomp.2015.04.011 [DOI] [PubMed] [Google Scholar]
  • 20.Tareque MI, Koshio A, Tiedt AD, Hasegawa T. Are the rates of hypertension and diabetes higher in people from lower socioeconomic status in Bangladesh? Results from a nationally representative survey. PLoS One. 2015;10:1–17. doi: 10.1371/journal.pone.0127954 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Biswas T, Townsend N, Islam MS, Islam MR, Das Gupta R, Das SK, et al. Association between socioeconomic status and prevalence of non-communicable diseases risk factors and comorbidities in Bangladesh: Findings from a nationwide cross-sectional survey. BMJ Open. 2019;9:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Biswas T, Islam MS, Linton N, Rawal LB. Socio-Economic Inequality of Chronic Non-Communicable Diseases in Bangladesh. PLoS One. 2016;11:1–12. doi: 10.1371/journal.pone.0167140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ali N, Akram R, Sheikh N, Sarker AR, Sultana M. Sex-specific prevalence, inequality and associated predictors of hypertension, diabetes, and comorbidity among Bangladeshi adults: Results from a nationwide cross-sectional demographic and health survey. BMJ Open. 2019;9:e029364. doi: 10.1136/bmjopen-2019-029364 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Saquib N, Khanam MA, Saquib J, Anand S, Chertow GM, Barry M, et al. High prevalence of type 2 diabetes among the urban middle class in Bangladesh. BMC Public Health. 2013;13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Akhter A, Fatema K, Ahmed SF, Afroz A, Ali L, Hussain A. Prevalence of Diabetes Mellitus and its Associated Risk Indicators in a Rural Bangladeshi Population. Open Diabetes J. 2011;4:6–13. [DOI] [PubMed] [Google Scholar]
  • 26.Black SA. Diabetes, diversity, and disparity: What do we do with the evidence? Am J Public Health. 2002;92:543–8. doi: 10.2105/ajph.92.4.543 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Rao JNK, Scott AJ. On chi-squared tests for multiway contingency tables with cell proportions estimated from survey data. Ann Stat. 1984;12:46–60. [Google Scholar]
  • 28.Rao JNK, Scott AJ. The analysis of categorical data from complex sample surveys: Chi-squared tests for goodness of fit and independence in two-way tables. J Am Stat Assoc. 1981;76:221–30. [Google Scholar]
  • 29.McHugh ML. The Chi-square test of independence. Biochem Med (Zagreb). 2013;23:143–9. doi: 10.11613/bm.2013.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Menyhart O, Weltz B, Gyorffy B. Multipletesting.com: A tool for life science researchers for multiple hypothesis testing correction. PLoS One. 2021;16:e0245824. doi: 10.1371/journal.pone.0245824 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Hailpern SM, Visintainer PF. Odds ratios and logistic regression: further examples of their use and interpretation. Stata J. 2003;3:213–25. [Google Scholar]
  • 32.Szumilas M. Information management for the busy practitioner explaining odds ratios. Journal of the Canadian Academy of Child and Adolescent Psychiatry. 2010;19:227–9. [PMC free article] [PubMed] [Google Scholar]
  • 33.World Health Organization. Diabetes Country Profiles 2016: Bangladesh. In: Global Report on Diabetes. Geneva: World Bank Office Dhaka; 2016. p. 2016.
  • 34.United Nations, Department of Economic and Social Affairs PD. World Population Prospects 2019. New York, NY: United Nations; 2019.
  • 35.Ahsan KZ, Alam MN, Nahar Q, Streatfield PK. Health systems reform focusing on multisectoral collaboration to achieve the Sustainable Development Goals: the case for epidemiologic transition in Bangladesh. In: 5th Global Symposium on Health Systems Research. Liverpool, UK; 2018. [Google Scholar]
  • 36.Vellakkal S, Subramanian S V., Millett C, Basu S, Stuckler D, Ebrahim S. Socioeconomic Inequalities in Non-Communicable Diseases Prevalence in India: Disparities between Self-Reported Diagnoses and Standardized Measures. PLoS One. 2013;8. doi: 10.1371/journal.pone.0068219 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Imam T, Hossain B. Diabetes Prevalence: a Comparison Between Urban and Rural Areas of Bangladesh. International Research Journal of Applied Life Sciences. 2012;1:114–26. [Google Scholar]
  • 38.Akter S, Rahman MM, Abe SK, Sultana P. Prevalence of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide survey. Bull World Health Organ. 2014;92:204–213A. doi: 10.2471/BLT.13.128371 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Sayeed MA, Ali L, Hussain MZ, Rumi MAK, Banu A, Khan AKA. Effect of socioeconomic risk factors on the difference in prevalence of diabetes between rural and urban populations in Bangladesh. Diabetes Care. 1997;20:551–5. doi: 10.2337/diacare.20.4.551 [DOI] [PubMed] [Google Scholar]
  • 40.Wubishet BL, Harris ML, Forder PM, Byles JE. Age and cohort rise in diabetes prevalence among older Australian women: Case ascertainment using survey and healthcare administrative data. PLoS One. 2020;15:1–15. doi: 10.1371/journal.pone.0234812 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Islam SMS, Lechner A, Ferrari U, Laxy M, Seissler J, Brown J, et al. Healthcare use and expenditure for diabetes in Bangladesh. BMJ Glob Health. 2017;2:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Grintsova O, Maier W, Mielck A. Inequalities in health care among patients with type 2 diabetes by individual socio-economic status (SES) and regional deprivation: A systematic literature review. Int J Equity Health. 2014;13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Goyal A, Yusuf S. The burden of cardiovascular disease in the Indian subcontinent. Indian Journal of Medical Research. 2006;124:235–44. [PubMed] [Google Scholar]
  • 44.Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, et al. Risk Factors for Early Myocardial Infarction in South Asians Compared With Individuals in Other Countries. J Am Med Assoc. 2007;297:286–94. doi: 10.1001/jama.297.3.286 [DOI] [PubMed] [Google Scholar]
  • 45.Islam N, Ullah GMS. Factors affecting consumers’ preferences on fast food items in Bangladesh. Journal of Applied Business Research. 2010;26:131–46. [Google Scholar]
  • 46.World Health Organization. Countdown to 2023: WHO report on global trans-fat elimination 2020. Geneva; 2020.
  • 47.Saleh F, Mumu SJ, Ara F, Begum HA, Ali L. Knowledge and self-care practices regarding diabetes among newly diagnosed type 2 diabetics in Bangladesh: A cross-sectional study. BMC Public Health. 2012;12:1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Hirai M, Grover N, Huang C. The measurement of non-communicable diseases in 25 countries with demographic and health surveys. DHS Occasional Papers No. 10. 2015. [Google Scholar]
  • 49.Bullard KM, Cowie CC, Lessem SE, Saydah SH, Menke A, Geiss LS, et al. Prevalence of Diagnosed Diabetes in Adults by Diabetes Type—United States, 2016. Morbidity and Mortality Weekly Report. 2018;67:2016–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Bream KDW, Breyre A, Garcia K, Calgua E, Chuc JM, Taylor L. Diabetes prevalence in rural Indigenous Guatemala: A geographic-randomized cross-sectional analysis of risk. PLoS One. 2018;13:1–12. doi: 10.1371/journal.pone.0200434 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Aekplakorn W, Chariyalertsak S, Kessomboon P, Assanangkornchai S, Taneepanichskul S, Putwatana P. Prevalence of diabetes and relationship with socioeconomic status in the Thai population: National health examination survey, 2004–2014. J Diabetes Res. 2018;2018. doi: 10.1155/2018/1654530 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Hamoudi R, Saheb Sharif-Askari N, Saheb Sharif-Askari F, Abusnana S, Aljaibeji H, Taneera J, et al. Prediabetes and diabetes prevalence and risk factors comparison between ethnic groups in the United Arab Emirates. Sci Rep. 2019;9:1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, et al. Diabetes in older adults. Diabetes Care. 2012;35:2650–64. doi: 10.2337/dc12-1801 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Bangladesh Bureau of Statistics (BBS). Report on Bangladesh Sample Vital Statistics 2019. Dhaka, Bangladesh: BBS; 2020.
  • 55.Berkowitz SA, Meigs JB, Wexler DJ. Age at type 2 diabetes onset and glycaemic control: results from the National Health and Nutrition Examination Survey (NHANES) 2005–2010. Diabetologia. 2013;56:2593–600. doi: 10.1007/s00125-013-3036-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Selvin E, Parrinello CM. Age-related differences in glycaemic control in diabetes. Diabetologia. 2013;56:2549–51. doi: 10.1007/s00125-013-3078-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.D’Adamo E, Caprio S. Type 2 diabetes in youth: Epidemiology and pathophysiology. Diabetes Care. 2011;34 SUPPL. 2:S161–5. doi: 10.2337/dc11-s212 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Nguyen NT, Nguyen XMT, Lane J, Wang P. Relationship between obesity and diabetes in a US adult population: Findings from the national health and nutrition examination survey, 1999–2006. Obes Surg. 2011;21:351–5. doi: 10.1007/s11695-010-0335-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Talukder A, Hossain MZ. Prevalence of Diabetes Mellitus and Its Associated Factors in Bangladesh: Application of Two-level Logistic Regression Model. Sci Rep. 2020;10:1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Howlader MZH, Biswas SK. Screening for nutritionally rich and low glycemic index Bangladeshi rice varieties. Dhaka: Food Planning and Monitoring Unit (FPMU), Ministry of Food and Disaster Management; 2009.
  • 61.Shozib HB, Bhowmick S, Jahan S, Hoque F, Alam S, Das SC, et al. In vivo screening of low glycemic index (GI) rice varieties in Bangladesh and evaluate the effect of differently processed rice and rice products on GI. Biojournal of Science and Technology. 2017;5. [Google Scholar]
  • 62.National Institute of Population Research and Training (NIPORT), ICF. Bangladesh Health Facility Survey 2017. Dhaka, Bangladesh; 2019.
  • 63.World Health Organization. Service Availability and Readiness Assessment (SARA): An annual monitoring system for service delivery. Geneva; 2015.
  • 64.Alam W, Nujhat S, Parajuli A, Banyira L, Mohsen WAM, Sutradhar I, et al. Readiness of primary health-care facilities for the management of non-communicable diseases in rural Bangladesh: a mixed methods study. Lancet Glob Health. 2020;8:S17. [Google Scholar]
  • 65.Islam MR, Laskar SP, Macer D. A Study on Service Availability and Readiness Assessment of Non-Communicable Diseases Using the WHO Tool for Gazipur District in Bangladesh. Bangladesh Journal of Bioethics. 2016;7:1–13. [Google Scholar]
  • 66.Moucheraud C. Service readiness for noncommunicable diseases was low in five countries in 2013–15. Health Aff. 2018;37:1321–30. doi: 10.1377/hlthaff.2018.0151 [DOI] [PubMed] [Google Scholar]
  • 67.Islam SMS, Uddin R, Zaman S Bin, Biswas T, Tansi T, Chegini Z, et al. Healthcare seeking behavior and glycemic control in patients with type 2 diabetes attending a tertiary hospital. Int J Diabetes Dev Ctries. 2020;:1–8. [Google Scholar]
  • 68.Government of Bangladesh. Annual Program Implementation Report (APIR) for the Health, Population, and Nutrition Sector Development Program (HPNSDP) 2011–16. Dhaka, Bangladesh; 2016.
  • 69.Diabetic Association of Bangladesh (BADAS), Directorate General of Health Services (DGHS). Diabetes Care: BADAS Guideline 2019. Dhaka; 2019.
  • 70.El-Saharty S, Ahsan KZ, Koehlmoos TLP, Engelgau MM. Tackling Noncommunicable Diseases in Bangladesh: Now is the time. Washington, D.C.; 2013. [Google Scholar]
  • 71.Islam SMS, Niessen LW, Ferrari U, Ali L, Seissler J, Lechner A. Effects of mobile phone sms to improve glycemic control among patients with type 2 diabetes in Bangladesh: A prospective, parallel-group, randomized controlled trial. Diabetes Care. 2015;38:e112–3. doi: 10.2337/dc15-0505 [DOI] [PubMed] [Google Scholar]
  • 72.Wakefield MA, Loken B, Hornik RC. Use of mass media campaigns to change health behaviour. The Lancet. 2010;376:1261–71. doi: 10.1016/S0140-6736(10)60809-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Ministry of Health and Family Welfare. Multi-sectoral Action Plan for Prevention & Control of Noncommunicable Diseases: 2018–2025. Dhaka: Noncommunicable Disease Control Programme, Directorate General of Health Services; 2018.

Decision Letter 0

Mohammad Bellal Hossain

8 Jul 2021

PONE-D-21-02392

Socioeconomic disparities in diabetes prevalence and management among the adult population in Bangladesh

PLOS ONE

Dear Dr. Ahsan,

Thank you for submitting your manuscript to PLOS ONE. Now I have received the review reports from two distinguished reviewers. I myself have gone through the manuscript meticulously with great interest. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please see my comments below in addition to the reviewers concern.

  1. The manuscript has lost its focus; it has failed to comply with the title. It its current format, the manuscript looks like a monograph though PLOS ONE has not problem with space. I do not see any justification for keeping the following sections in the manuscript: Correlates of diabetes among women of reproductive age; and Changes in correlates of diabetes between 2011 and 2017-18 among older adults. Please consider removing these two sections to make a focused manuscript.

  2. The tables should provide the 'n' in any format to demonstrate the sample size f different outcome variables.

Please submit your revised manuscript by Aug 22 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mohammad Bellal Hossain

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thanks authors for analysing the latest data from the Bangladesh Demographic and Health Survey (BDHS) to explore socioeconomic disparities in diabetes prevalence and management among the adult population in Bangladesh. This study is important to understand the growing burden of diabetes in Bangladesh. However, this manuscript does need major revisions with clarification, particularly in the methods and analysis section. I do have few questions and changes to suggest:

Major comments:

- As suggested by the IDF, we cannot label respondents as diabetic patients. It should be, ‘people with diabetes’. Please change throughout the manuscript.

- The current title is not consistent with the way the authors analyse and reported data. According to the title, the authors should consider socioeconomic status (SES) as exposure and adjust all the confounders rather than putting all of them in kitchen sink regression model.

- The manuscript is written poorly with a lack of clear direction. For example, the focus of the manuscript is on the socioeconomic disparities in diabetes prevalence, however, most of the literature are not in relation to the issue. Secondly, the authors defined type2, type1, GDM and provided every detail of global prevalence which are not needed, while diabetes management, an important part of the manuscript, is completely ignored.

- It is not appropriate to investigate the changes of risk factors, especially for time variants factors e.g. age, BMI, and hypertension status, when they modelled each survey data separately.

- The BMI should be categorised based on Asian cut-off as suggested by the WHO expert consultation due to the high risk of type 2 diabetes and cardiovascular disease in Asian people at lower BMIs than the existing WHO cut-off. However, it is not clear whether the authors used Asian or WHO cut-off. About ~17 % of the study population is underweight that has differential impact on diabetes. So, I suggest not to combine underweight and normal weight.

- It is not appropriate to combine wealth quintiles.

- It is unclear whether the authors checked multi-collinearity, interaction or effect modification in the data.

- When the overall prevalence of diabetes is >10% (especially for table 5). For such a common outcome, logistic regression (odds ratio) overestimates or jeopardizes the association. So, the adjusted association (Odds ratio) might be just by chance, not the true association. Prevalence ratio is the suitable option for a cross-sectional study with a common outcome, while the odds ratio is the best option for a case-control study or the rare outcome. Authors can consult with log-binomial or other advanced methods for calculating adjusted prevalence ratio.

- Please provide flowchart of analytic sample. The final report shows that total sample was 12099 (table 13.5.1: women 6918, table13.5.4:men 5181), including pregnant women. However, your analytic sample is 12092 which is only 7 women less compared to the national report.

- For subgroup analysis of women, number of pregnancies/parity should be adjusted in the model.

- For table 2, please report overall numerator and denominator.

- Results should be reported precisely. Prevalence should be reported with 95%CI both in the table and in the text.

- The discussion is sloppy. Policy suggestions for diabetes management need to be compact as currently reported as literature review.

- The manuscript must be edited by a native speaker.

Reviewer #2: 1) General comments and summary of recommendation

Describe your overall impressions of the submission, how it fits within the scope of the journal, and your recommendation.

This is an interesting and worthwhile analysis of an important issue in countries such as Bangladesh. The paper focus on sociodemographic disparities and not just socioeconomic.

General comments would be to talk about people with diabetes rather than diabetics. I understand from clinical colleagues that there is a move away from labelling people based on their disease status.

2) Content:

Please consider the originality, relevance and rigour of the submission and the author’s depth of understanding of the issues being researched. Please comment on the adequacy of the author’s referencing and whether or not the existing knowledge base has been explored and built upon.

Please examine the methodologies used and their appropriateness, and the author’s use of the evidential base. Is all statistical analysis sound? Does it need to be checked further by a statistical expert? Does the conclusion reflect the argument in the main body text, is it supported by factual data, and does it bring something new to the debate? Overall, is the submission scientifically sound?

This is a well thought through paper on an important issue. I have some concerns that should be addressed before the paper is ready for publication.

Major

1. The sample size is small for doing multiple comparisons, and this should be acknowledged.

2. Please give exact p-values unless p<0.0001.

3. There are probably >100 p-values in this paper and so it is inappropriate to focus on any <0.05.

4. Have the authors considered doing a global test for heterogeneity in their tables?

5. On a similar note, it would be more appropriate to calculate tests for trend for factors that show a trend (eg SES, education, etc).

6. Please describe ORs consistently. On line 278, the OR is described as being 31% higher and 2.4 times higher. We do not normally refer to ORs in terms of percentages. Similarly, on line 258 they are referred to as likelihood.

7. I would prefer to

Minor

1. In the Introduction, line 107, please talk about a decline in the probability of dying prematurely (since the probability of dying=1 in all countries).

2. Line 193: please clarify that ‘hypertensive’ refers to measured hypertensive and so there might be some participants with a diagnosis of hypertension who are controlled by medication. This is fine, but it should be clarified.

3. Table 3: BMI is not nutritional status, please re-label.

4. I would prefer to see SES defined as low, middle, high rather than poor, middle and rich.

3) Structure and argument:

Do the Highlights capture the novel points of interest of the paper? Does the abstract summarise the arguments in a succinct and accurate way? Is the manuscript logically structured and do the arguments flow coherently? Does the introduction signpost the arguments and is there enough reference to methodology in the introduction to substantiate the arguments? Do the Material and Methods provide sufficient details to allow the work to be reproduced by an independent researcher? Are the results clear and concise? Please indicate if there is redundancy of information given in text and tables/figures that can be eliminated. Does the conclusion adequately summarise the main results?

All OK.

4) Figures/tables:

Please comment on the author’s use of tables, charts, figures or maps – their relevance in terms of illustrating the arguments and supporting the evidential base, the quality of the formatting and presentation.

The tables require some work. The use of * to indicate p<0.05, <0.001, etc is inappropriate (as already mentioned). There should be tests for trend and it would be better to use floating absolute risks (Easton et al, 1991, Plummer et al 2004) so that appropriate uncertainty is allocated to the reference group and therefore comparisons can be made between any 2 groups and not just with the reference group.

The figures are inadequate.

Figure 1 needs N and Cis so that the reader can determine how reliably each prevalence has been determined.

Figure 2: the y-axis should be ‘% of those with diabetes’. The current tile implies that 100% of the population aged 18 years or older has diabetes.

5) Language:

Is the text well written (i.e. clear to read) and jargon free? Please comment on the quality of English and need for grammatical improvement.

The language and grammar are adequate.

6) Ethical approval:

If humans or animals have been used as research subjects, are statements of ethical approval by a relevant authority present? Where humans have participated in research, informed consent should also be declared. If not present, please detail where you think a further ethics approval/statement is required.

n/a

7) Data availability:

Has data used in the study been adequately described and made available? Is the data curated in a usable format? Is there a 'Data Availability Statement' prior to the reference list providing information on how to access the data, or information on why it has not been made public?

The analyses use publicly available data.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Dec 20;17(12):e0279228. doi: 10.1371/journal.pone.0279228.r002

Author response to Decision Letter 0


22 Aug 2021

Comments from the Editor

1. The manuscript has lost its focus; it has failed to comply with the title. It its current format, the manuscript looks like a monograph though PLOS ONE has not problem with space. I do not see any justification for keeping the following sections in the manuscript: Correlates of diabetes among women of reproductive age; and Changes in correlates of diabetes between 2011 and 2017-18 among older adults. Please consider removing these two sections to make a focused manuscript.

Authors’ Response: The sections “Correlates of diabetes among women of reproductive age” and “Changes in correlates of diabetes between 2011 and 2017-18 among older adults” are dropped (p.18, line 342 to p.20, line 392 in the revised manuscript with track changes). Abstract, Methods, and Discussion sections have been updated accordingly.

2. The tables should provide the ‘n’ in any format to demonstrate the sample size f different outcome variables.

Authors’ Response: Updated Table 3 (p.16) by adding ‘n.’

3. Please ensure that your manuscript meets PLOS ONE’s style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Authors’ Response: The manuscript has been reviewed to ensure that it meets PLOS ONE style requirements.

4. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

Authors’ Response: We added a subsection on ethics approval under the Methods section (p.11, lines 233–239).

Comments from Reviewer 1

1. As suggested by the IDF, we cannot label respondents as diabetic patients. It should be, ‘people with diabetes’. Please change throughout the manuscript.

Authors’ Response: We thank the reviewer for highlighting this important point. We have replaced ‘diabetics/diabetic patients’ with ‘people with diabetes’ throughout the manuscript.

2. The current title is not consistent with the way the authors analyse and reported data. According to the title, the authors should consider socioeconomic status (SES) as exposure and adjust all the confounders rather than putting all of them in kitchen sink regression model.

Authors’ Response: As per the manuscript’s title, we consider SES as exposure and have built the multivariate model in a stepwise approach (viz., first running the bivariate tables, then putting the potential confounders one by one, testing interactions between SES and the cofounders, and using the goodness of fit test to decide on the final list of variables). We believe that the statistical measures and approach used in the analysis are appropriate to achieve the objectives of the study. In addition, the title also aligns with the analysis, results found, and possible explanations of the findings.

3. The manuscript is written poorly with a lack of clear direction. For example, the focus of the manuscript is on the socioeconomic disparities in diabetes prevalence, however, most of the literature are not in relation to the issue. Secondly, the authors defined type2, type1, GDM and provided every detail of global prevalence which are not needed, while diabetes management, an important part of the manuscript, is completely ignored.

Authors’ Response: We are surprised that the reviewer feels this way. Out of 6 paragraphs in the introduction section, only one paragraph broadly discussed the global context before getting into the country context. Also, diabetes management and its relation to socioeconomic disparity are noted based on the literature review (p.6, lines 123–128), so it was not completely ignored.

4. It is not appropriate to investigate the changes of risk factors, especially for time variants factors e.g. age, BMI, and hypertension status, when they modelled each survey data separately.

Authors’ Response: Following the Editor’s recommendation, we dropped the section on “Changes in correlates of diabetes between 2011 and 2017-18 among older adults.”

5. The BMI should be categorised based on Asian cutoff as suggested by the WHO expert consultation due to the high risk of type 2 diabetes and cardiovascular disease in Asian people at lower BMIs than the existing WHO cutoff. However, it is not clear whether the authors used Asian or WHO cut-off. About ~17 % of the study population is underweight that has differential impact on diabetes. So, I suggest not to combine underweight and normal weight.

Authors’ Response: We agree that some literature has used different BMI categories, particularly for studies in Asia. We, however, decided to use the most widely used and internationally accepted categories of BMI for our analysis. In addition, the Government of Bangladesh also uses these BMI cut-offs for program monitoring and strategic planning purposes.

We re-analyzed data without combining underweight and normal BMIs and updated the manuscript accordingly.

6. It is not appropriate to combine wealth quintiles.

Authors’ Response: We respectfully disagree with the reviewer’s comment. DHS asset index is a relative index for comparing households or individuals within one survey. Combining wealth quintiles or creating quantiles/terciles from the asset index to differentiate the poor and non-poor respondents is a common, standard practice and published many times in reputable journals (including PLOS ONE). Our re-categorization of the quintiles was primarily based on both old and new study findings, which showed that the households in the two lowest wealth quintiles can be considered as the ‘low socioeconomic status’ for a lower-middle-income country like Bangladesh.

7. It is unclear whether the authors checked multi-collinearity, interaction or effect modification in the data.

Authors’ Response: We checked for multicollinearity, interactions between SES and the covariates, and effect modifications in the dataset. We added texts describing this in pp.9–10, lines 203–208.

8. When the overall prevalence of diabetes is >10% (especially for table 5). For such a common outcome, logistic regression (odds ratio) overestimates or jeopardizes the association. So, the adjusted association (Odds ratio) might be just by chance, not the true association. Prevalence ratio is the suitable option for a cross-sectional study with a common outcome, while the odds ratio is the best option for a case-control study or the rare outcome. Authors can consult with log-binomial or other advanced methods for calculating adjusted prevalence ratio.

Authors’ Response: Following the Editor’s recommendation, we dropped the section on “Changes in correlates of diabetes between 2011 and 2017-18 among older adults.” The overall prevalence of diabetes in our main analysis remains under 10%, and therefore, we reported the outcomes using logistic regression models.

9. Please provide flowchart of analytic sample. The final report shows that total sample was 12099 (table 13.5.1: women 6918, table13.5.4:men 5181), including pregnant women. However, your analytic sample is 12092 which is only 7 women less compared to the national report.

Authors’ Response: We provided a flowchart in the supplement (Fig S1).

10. For subgroup analysis of women, number of pregnancies/parity should be adjusted in the model.

Authors’ Response: Following the Editor’s recommendation, we dropped the section on “Correlates of diabetes among women of reproductive age.”

11. For table 2, please report overall numerator and denominator.

Authors’ Response: Table 2 already has the denominator (number of respondents) reported. We tried putting the frequencies in each cell, but then the table becomes hard to read. No changes were made.

12. The discussion is sloppy. Policy suggestions for diabetes management need to be compact as currently reported as literature review.

Authors’ Response: We made some adjustments to streamline the discussion section. We would be benefitted from specific comments on how the discussion section can be improved instead of a sweeping statement from the reviewer.

13. The manuscript must be edited by a native speaker.

Authors’ Response: The manuscript has a native English-speaking and at least one co-author highly proficient in English, and they thoroughly reviewed the manuscript. We request the reviewer to point out the exact places in the revised manuscript where it is felt that further correction is needed to meet the desired standards.

Comments from Reviewer 2

1. General comments would be to talk about people with diabetes rather than diabetics. I understand from clinical colleagues that there is a move away from labelling people based on their disease status.

Authors’ Response: We thank the reviewer for highlighting this important issue. We have replaced ‘diabetics/diabetic patients’ with ‘people with diabetes’ throughout the manuscript.

2. The sample size is small for doing multiple comparisons, and this should be acknowledged.

Authors’ Response: Following the Editor’s recommendation, we dropped the section on “Changes in correlates of diabetes between 2011 and 2017-18 among older adults.” The analysis in the revised manuscript is based on a representative sample of the adult population in Bangladesh for 2017-18.

3. Please give exact p-values unless p<0.0001.

Authors’ Response: Table 3 has been revised following the PLOS One’s submission guideline. We reported exact p-values for all values greater than or equal to 0.001 and p-values less than 0.001 were expressed as p<0.001.

4. There are probably >100 p-values in this paper and so it is inappropriate to focus on any <0.05.

Authors’ Response: After dropping the additional analyses as per the Editor’s recommendation, the number of p-values has declined substantially. No changes were made.

5. Have the authors considered doing a global test for heterogeneity in their tables?

Authors’ Response: Testing for heterogeneity is important for meta-analysis or panel data analysis. It helps to deal with different study designs, different interventions, etc., and to take necessary analytical actions. However, following the Editor’s recommendation, our revised manuscript relies on one nationally repetitive cross-sectional survey data. We, therefore, respectfully disagree with the reviewer that performing a test for heterogeneity is essentially applicable to our analysis.

6. On a similar note, it would be more appropriate to calculate tests for trend for factors that show a trend (eg SES, education, etc).

Authors’ Response: Following the Editor’s recommendation, we dropped the section on “Changes in correlates of diabetes between 2011 and 2017-18 among older adults.” The revised manuscript no longer compares the trends over two time points.

7. Please describe ORs consistently. On line 278, the OR is described as being 31% higher and 2.4 times higher. We do not normally refer to ORs in terms of percentages. Similarly, on line 258 they are referred to as likelihood.

Authors’ Response: We updated the texts (in pp.15–17) in line with the reviewer’s comment.

8. In the Introduction, line 107, please talk about a decline in the probability of dying prematurely (since the probability of dying=1 in all countries).

Authors’ Response: We made the suggested change (p.5, line 107).

9. Line 193: please clarify that ‘hypertensive’ refers to measured hypertensive and so there might be some participants with a diagnosis of hypertension who are controlled by medication. This is fine, but it should be clarified.

Authors’ Response: We updated the texts (in p.9, lines 199–201) to reflect the reviewer’s comment.

10. Table 3: BMI is not nutritional status, please re-label.

Authors’ Response: BMI is a commonly used measure of adult nutritional status for a long time. No changes were made.

11. I would prefer to see SES defined as low, middle, high rather than poor, middle and rich.

Authors’ Response: We made the suggested change.

12. The tables require some work. The use of * to indicate p<0.05, <0.001, etc is inappropriate (as already mentioned). There should be tests for trend and it would be better to use floating absolute risks (Easton et al, 1991, Plummer et al 2004) so that appropriate uncertainty is allocated to the reference group and therefore comparisons can be made between any 2 groups and not just with the reference group.

Authors’ Response: The revised manuscript does not include the 2011 BDHS data. So, the ‘tests for trend’ is no longer an issue.

In proportional hazards model and conditional logistic regression model for matched case-control studies, floating absolute risk (FAR) is used for estimating the CI for relative risk for each category of a factor variable including the reference group. However, FAR method has several criticisms and we do not find it necessary to achieve the objectives of this study. Therefore, we respectfully disagree with the reviewer and followed the conventional approach (using a reference category) for factor variable.

13. The figures are inadequate. Figure 1 needs N and Cis so that the reader can determine how reliably each prevalence has been determined.

Authors’ Response: We updated Figure 1 by adding CI (Fig-1_R1.svg).

14. Figure 2: the y-axis should be ‘% of those with diabetes’. The current tile implies that 100% of the population aged 18 years or older has diabetes.

Authors’ Response: We updated Figure 2 after incorporating the reviewer’s comment (Fig-2_R1.svg).

Attachment

Submitted filename: Response to reviewers_R1.docx

Decision Letter 1

Mohammad Bellal Hossain

18 Jul 2022

PONE-D-21-02392R1

Socioeconomic disparities in diabetes prevalence and management among the adult population in Bangladesh

PLOS ONE

Dear Dr. Ahsan,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 01 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mohammad Bellal Hossain

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: (No Response)

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Partly

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: My major concern remaining is the multitude of p-values in this paper, with no acknowledgement of or correction for multiple testing.

Reviewer #3: The are several details of the statistical analysis missing in the current version of the paper.

1. Table 2 does not include information about the sample size used for the test.

2. The Chi-square test used for table 2 is not sufficiently explained. Please add more details what has been compared and why are there no alternative tests.

3. Table 3 does not include information about the sample size used for the test.

4. Add the mathematical definition of aOR (adjusted odds ratio) used in table 3 to the main text. Explain in detail what has been adjusted.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Dec 20;17(12):e0279228. doi: 10.1371/journal.pone.0279228.r004

Author response to Decision Letter 1


1 Sep 2022

Comment from Reviewer 2

1. My major concern remaining is the multitude of p-values in this paper, with no acknowledgement of or correction for multiple testing.

Authors’ Response: For our bivariate analyses (i.e., chi-squared tests), we used the Bonferroni-corrected p-value to examine the association between selected explanatory variables and diabetes prevalence, awareness, treatment, and control (p.13, lines 264–267). Since the multivariable regression analyses in this study were conducted separately for diabetes prevalence, awareness, treatment, and control, we did not correct for multiple testing, and we acknowledged this limitation on p.28, lines 580–583.

Comments from Reviewer 3

1. Table 2 does not include information about the sample size used for the test.

Authors’ Response: Sample sizes (i.e., the number of respondents) are provided in the last row of Table 2 (p.14).

2. The Chi-square test used for table 2 is not sufficiently explained. Please add more details what has been compared and why are there no alternative tests.

Authors’ Response: We thank the reviewer for this constructive comment. We added texts (and references) on pp.9–10, lines 204–218, to explain our choice of chi-squared tests.

3. Table 3 does not include information about the sample size used for the test.

Authors’ Response: Sample sizes (i.e., the number of respondents) are provided in the last row of Table 3 (p.17).

4. Add the mathematical definition of aOR (adjusted odds ratio) used in table 3 to the main text. Explain in detail what has been adjusted.

Authors’ Response: We added texts explaining aORs on p.15, lines 307–314.

Attachment

Submitted filename: Response to reviewers_R2.docx

Decision Letter 2

Mohammad Bellal Hossain

14 Oct 2022

PONE-D-21-02392R2Socioeconomic disparities in diabetes prevalence and management among the adult population in BangladeshPLOS ONE

Dear Dr. Ahsan,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please note that in your manuscript you have stated (Lines 184 to 187) “Body mass index (BMI) was categorized into three groups—underweight/normal if BMI is less than 25 kg/m2, overweight or obese if BMI is 25 kg/m2 or above, and unknown for the respondents whose height and/or weight data were not available. However, in all of your tables, you have presented it as Nutritional status with the following categories: Underweight, Normal, Overweight/obese, and Unknown. I recommend to use to use BMI; not Nutritional status with the following categories: underweight, normal, overweight or obese, and unknown. It will not be good to merge the underweight with normal.  

Please submit your revised manuscript by Nov 28 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mohammad Bellal Hossain

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: I still think the authors have not made clear in table 1 that 'Nutritional status' is based on BMI and vice versa in the text that "Body-mass index (BMI) was categorized into three groups..." is referred to as 'Nutritional status' in Table 1.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Dec 20;17(12):e0279228. doi: 10.1371/journal.pone.0279228.r006

Author response to Decision Letter 2


27 Nov 2022

Comment from the Editor

1. Please note that in your manuscript you have stated (Lines 184 to 187) “Body mass index (BMI) was categorized into three groups—underweight/normal if BMI is less than 25 kg/m2, overweight or obese if BMI is 25 kg/m2 or above, and unknown for the respondents whose height and/or weight data were not available. However, in all of your tables, you have presented it as Nutritional status with the following categories: Underweight, Normal, Overweight/obese, and Unknown. I recommend to use to use BMI; not Nutritional status with the following categories: underweight, normal, overweight or obese, and unknown. It will not be good to merge the underweight with normal.

Authors’ Response: We are sorry for this oversight. Based on the reviewer’s comments in an earlier review, we re-analyzed the data using four categories of BMI, and underweight with normal are no longer merged in the current analyses. We have corrected the variable description on p.8, lines 181–182. We also replaced ‘Nutritional status’ with ‘BMI’ throughout the manuscript.

Comment from Reviewer 2

1. I still think the authors have not made clear in table 1 that 'Nutritional status' is based on BMI and vice versa in the text that "Body-mass index (BMI) was categorized into three groups..." is referred to as 'Nutritional status' in Table 1.

Authors’ Response: We have corrected the variable description on p.8, lines 181–182. We also replaced ‘Nutritional status’ with ‘BMI’ throughout the manuscript.

Attachment

Submitted filename: Response to reviewers_R3.docx

Decision Letter 3

Mohammad Bellal Hossain

5 Dec 2022

Socioeconomic disparities in diabetes prevalence and management among the adult population in Bangladesh

PONE-D-21-02392R3

Dear Dr. Ahsan,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mohammad Bellal Hossain

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Mohammad Bellal Hossain

12 Dec 2022

PONE-D-21-02392R3

Socioeconomic disparities in diabetes prevalence and management among the adult population in Bangladesh

Dear Dr. Ahsan:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Mohammad Bellal Hossain

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (DOCX)

    Attachment

    Submitted filename: Response to reviewers_R1.docx

    Attachment

    Submitted filename: Response to reviewers_R2.docx

    Attachment

    Submitted filename: Response to reviewers_R3.docx

    Data Availability Statement

    The survey data reported in this manuscript are publicly available via the DHS Program. The BDHS 2017-18 datasets are freely available from the following website: http://dhsprogram.com/data/available-datasets.cfm.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES